×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Apogee Therapeutics Inc.. (APGE) NASDAQ

$48.88 2.84 (6.17%)

Market Cap: $2.07B

As of 05/24/24 12:32 PM EDT. Market open.

(APGE)

Apogee Therapeutics Inc.. (APGE)
NASDAQ

$48.88
2.84 (6.17%)

Market Cap: $2.07B

As of 05/24/24 12:32 PM EDT. Market open.

Add to Portfolio
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
PRICE CHART FOR APOGEE THERAPEUTICS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$47.10
Previous Close
$46.04
Days Range
$45.85 - $48.39
52 week range
$14.19 - $72.29
Volume
156,331
Avg. Volume (30 days)
412,432
Market Cap
$2.07B
Dividend Yield
-
P/E
-
Shares Outstanding
44,969,385
Open
$47.10
Previous Close
$46.04
Days Range
$45.85 - $48.39
52 week range
$14.19 - $72.29
Volume
156,331
Avg. Volume (30 days)
412,432
Market Cap
$2.07B
Dividend Yield
-
P/E
-
Shares Outstanding
44,969,385
FINANCIAL STATEMENTS FOR APOGEE THERAPEUTICS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APOGEE THERAPEUTICS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Shah Nimish PDirectorJul 13, 2023 Buy$17.001,750,00029,750,0001,750,000Jul 17, 2023, 08:00 PM
Fairmount Funds Management LLCDirectorJul 13, 2023 Buy$17.0055,913950,52155,913Jul 17, 2023, 08:00 PM
Fairmount Funds Management LLCDirectorJul 13, 2023 Buy$17.00892,52915,172,993892,529Jul 17, 2023, 08:00 PM
Fairmount Funds Management LLCDirectorJul 13, 2023 Buy$17.001,992,73433,876,4781,992,734Jul 17, 2023, 08:00 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Shah Nimish PDirector07/13/202329,750,000
Fairmount Funds Management LLCDirector07/13/2023950,521
Fairmount Funds Management LLCDirector07/13/202315,172,993
Fairmount Funds Management LLCDirector07/13/202333,876,478
FUNDS WITH A POSITION IN APOGEE THERAPEUTICS INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.2,809,8250.00435%70.91%Other
DRIEHAUS CAPITAL MANAGEMENT LLC2,063,7631.37%55.28%Growth
RA CAPITAL MANAGEMENT, L.P.1,977,9011.69%No changeOther
ORBIMED ADVISORS LLC718,9010.87%-43.74%Other
GEODE CAPITAL MANAGEMENT, LLC761,0240.00468%72.38%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.175,0000.02%-66.67%Other
VIVO CAPITAL, LLC400,0000.92%ExitedOther
BLACKSTONE INC.230,0000.06%-34.62%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)329,0000.38%NewOther
FARALLON CAPITAL MANAGEMENT LLC305,0000.09%NewEvent Driven, Value
PLATINUM INVESTMENT MANAGEMENT LTD167,8780.45%-40.82%Growth At A Reasonable Price, Value
HOLOCENE ADVISORS, LP101,2020.01%ExitedGrowth At A Reasonable Price
CANDRIAM S.C.A.90,0000.04%NewOther
RENAISSANCE TECHNOLOGIES LLC88,7000.00926%NewOther
TUDOR INVESTMENT CORP ET AL12,5220.00529%NewEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.3,5610.00041%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR APOGEE THERAPEUTICS INC.
STOCK BUYBACKS FOR APOGEE THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
09/30/2023
21.73%
2Q

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
21.73%
2Q
BUYBACK ANNOUNCEMENT(S) FOR APOGEE THERAPEUTICS INC.
LOADING...